Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib versus selumetinib plus weekly paclitaxel in metastatic uveal melanoma
2014-004437-22Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of selumetinib and paclitaxel in intraocular melanoma and eye melanoma (3 arms), sponsored by University of Liverpool. Primary endpoint: Progression-free survival. Started Jul 2015; status: completed.
02
Drugs
selumetinibpaclitaxel
03
Conditions
intraocular melanomaeye melanoma
Beyond the preview
Go deeper on 2014-004437-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004437-22.